Growth hormone-STAT5 regulation of growth, hepatocellular carcinoma, and liver metabolism
- PMID: 21793836
- PMCID: PMC3427656
- DOI: 10.1111/j.1749-6632.2011.06100.x
Growth hormone-STAT5 regulation of growth, hepatocellular carcinoma, and liver metabolism
Abstract
The liver is a primary target of growth hormone (GH). GH signals are mediated by the transcription factor signal transducer and activator of transcription 5 (STAT5). Here, we focus on recent discoveries about the role of GH-STAT5 signaling in hepatic physiology and pathophysiology. We discuss roles of the GH-STAT5 axis in body growth, lipid metabolism, and the cell cycle pertaining to hepatosteatosis, fibrosis, and hepatocellular carcinoma. Finally, we discuss recent discoveries about the role of GH-STAT5 in sex-specific gene expression and bile acid, steroid, and drug metabolism.
© 2011 New York Academy of Sciences.
Conflict of interest statement
Conflicts of interest
Figures
References
-
- Kofoed EM, Hwa V, Little B, et al. Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med. 2003;349:1139–1147. - PubMed
-
- Chia DJ, Ono M, Woelfle J, et al. Characterization of distinct Stat5b binding sites that mediate growth hormone-stimulated IGF-I gene transcription. J Biol Chem. 2006;281:3190–3197. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
